Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types

被引:105
作者
Sumi, Misa [1 ]
Nakamura, Takashi [1 ]
机构
[1] Nagasaki Univ, Sch Dent, Dept Radiol & Canc Biol, Nagasaki 8528588, Japan
基金
日本学术振兴会;
关键词
Diffusion-weighted MR imaging; Intravoxel incoherent motion theory; Contrast-enhanced MR imaging; Head and neck tumours; Differential diagnosis; SALIVARY-GLAND TUMORS; COEFFICIENT-BASED DIFFERENTIATION; DIFFUSION; BENIGN; PERFUSION; NODES;
D O I
10.1007/s00330-013-3002-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
Objectives We evaluated the combined use of intravoxel incoherent motion (IVIM) and time-signal intensity curve (TIC) analyses to diagnose head and neck tumours. Methods We compared perfusion-related parameters (PP) and molecular diffusion values (D) determined from IVIM theory and TIC profiles among 92 tumours with different histologies. Results IVIM parameters (f and D values) and TIC profiles in combination were distinct among the different types of head and neck tumours, including squamous cell carcinomas (SCCs), lymphomas, malignant salivary gland tumours, Warthin's tumours, pleomorphic adenomas and schwannomas. A multiparametric approach using both IVIM parameters and TIC profiles differentiated between benign and malignant tumours with 97 % accuracy and diagnosed different tumour types with 89 % accuracy. Conclusions Combined use of IVIM parameters and TIC profiles has high efficacy in diagnosing head and neck tumours. Key points Head and neck tumours have wide MR perfusion/diffusion properties. Dynamic contrast-enhanced (DCE) MR imaging can characterise tumour perfusion (TIC analysis). Intravoxel incoherent motion (IVIM) imaging can provide diffusion and perfusion properties. However, IVIM or DCE imaging alone is insufficient for diagnosing head/neck tumours. Multiparametric approach using both IVIM and TIC profiles can facilitate the diagnosis.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 19 条
[1]
Prediction of Disease-Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging [J].
Chawla, S. ;
Kim, S. ;
Loevner, L. A. ;
Hwang, W. -T. ;
Weinstein, G. ;
Chalian, A. ;
Quon, H. ;
Poptani, H. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (04) :778-784
[2]
Eida S, 2007, AM J NEURORADIOL, V28, P116
[3]
MR factor analysis: Improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors [J].
Eida, Sato ;
Ohki, Masafumi ;
Sumi, Misa ;
Yamada, Toshiro ;
Nakamura, Takashi .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (06) :1256-1262
[4]
Multiparametric Magnetic Resonance Imaging for the Differentiation Between Benign and Malignant Salivary Gland Tumors [J].
Eida, Sato ;
Sumi, Misa ;
Nakamura, Takashi .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 31 (03) :673-679
[5]
Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla [J].
Furukawa, Matakazu ;
Parvathaneni, Upendra ;
Maravilla, Kenneth ;
Richards, Todd L. ;
Anzai, Yoshimi .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (07) :923-929
[6]
Intravoxel Incoherent Motion Diffusion-weighted Imaging in Nonalcoholic Fatty Liver Disease: A 3.0-T MR Study [J].
Guiu, Boris ;
Petit, Jean-Michel ;
Capitan, Violaine ;
Aho, Serge ;
Masson, David ;
Lefevre, Pierre-Henri ;
Favelier, Sylvain ;
Loffroy, Romaric ;
Verges, Bruno ;
Hillon, Patrick ;
Krause, Denis ;
Cercueil, Jean-Pierre .
RADIOLOGY, 2012, 265 (01) :96-103
[7]
Harnsberger HR., 2004, Diagnostic imaging: head and neck
[8]
Prediction of Response to Chemoradiation Therapy in Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging [J].
Kim, S. ;
Loevner, L. A. ;
Quon, H. ;
Kilger, A. ;
Sherman, E. ;
Weinstein, G. ;
Chalian, A. ;
Poptani, H. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (02) :262-268
[9]
Looking into the functional architecture of the brain with diffusion MRI [J].
Le Bihan, D .
NATURE REVIEWS NEUROSCIENCE, 2003, 4 (06) :469-480
[10]
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study [J].
Lewin, Maiete ;
Fartoux, Laetitia ;
Vignaud, Alexandre ;
Arrive, Lionel ;
Menu, Yves ;
Rosmorduc, Olivier .
EUROPEAN RADIOLOGY, 2011, 21 (02) :281-290